Aptinyx Inc (APTX)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Andrew Kidd
Employees:
40
1801 MAPLE AVENUE, SUITE 4300, EVANSTON, IL 60201
847-871-0377

Aptinyx Inc. focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. The company has a research collaboration agreement with Allergan plc.

Data derived from most recent annual or quarterly report
Market Cap 4.131 Million Shares Outstanding67.716 Million Avg 30-day Volume 3.372 Million
P/E Ratio0.0 Dividend Yield0.0 EPS-0.98
Price to Revenue0.0 Debt to Equity1.3748 EBITDA-62.4 Million
Price to Book Value0.4629 Operating Margin0.0 Enterprise Value-11.203 Million
Current Ratio5.123 EPS Growth0.169 Quick Ratio4.781
1 Yr BETA 0.4763 52-week High/Low 0.74 / 0.06 Profit Margin0.0
Operating Cash Flow Growth21.6585 Free Cash Flow to Firm (FCFF) TTM -41.639 Million Free Cash Flow to Equity (FCFE) TTM-44.446 Million
Altman Z-Score-14.08
View SEC Filings from APTX instead.

View recent insider trading info

Aptinyx Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding APTX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding APTX

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2023-01-05 by KHANNA ASHISH
  • 4: filed on 2023-01-05 by RIEDEL NORBERT G
  • 4: filed on 2023-01-05 by KIDD ANDREW
  • 4: filed on 2022-05-31 by KOPPEL ADAM
  • 4: filed on 2022-05-31 by O'NEILL GILMORE NEIL
  • 4: filed on 2022-05-31 by MILLER JOAN W.
  • 4: filed on 2022-05-31 by GOSEBRUCH HENRY O
  • 4: filed on 2022-05-31 by HOMBACH ROBERT J.
  • 4: filed on 2022-05-31 by SHERMAN RACHEL E.
  • 4: filed on 2022-05-31 by ENRIGHT PATRICK G

    • Events (8k)

  • 8-K: filed on 2023-07-03:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 5.07: Submission of Matters to a Vote of Security Holders
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-05-11:
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
  • 8-K: filed on 2023-05-05:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-04-25:
    Item 1.02: Termination of a Material Definitive Agreement
  • 8-K: filed on 2023-04-18:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2023-03-30:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-03-01:
    Item 2.05: Cost Associated with Exit or Disposal Activities
  • 8-K: filed on 2023-02-27:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-12-08:
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
  • 8-K: filed on 2022-12-01:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    RIEDEL NORBERT G EXECUTIVE CHAIRMAN OF THE BOD

    • Officer
    • Director
    		 420,000 2023-01-03 1

    KIDD ANDREW PRESIDENT AND CEO

    • Officer
    • Director
    		 700,000 2023-01-03 1

    KHANNA ASHISH CFO AND CBO

    • Officer
    		 375,000 2023-01-03 1

    ENRIGHT PATRICK G

    • Director
    		 3,491,746 2022-05-26 0

    HOMBACH ROBERT J.

    • Director
    		 269,100 2022-05-26 0

    GOULD TERRY P

    • Director
    		 4,070,628 2022-05-26 0

    KOPPEL ADAM

    • Director
    • 10% Owner
    		 40,000 2022-05-26 0

    GOSEBRUCH HENRY O

    • Director
    		 165,000 2022-05-26 0

    O'NEILL GILMORE NEIL

    • Director
    		 40,000 2022-05-26 0

    SHERMAN RACHEL E.

    • Director
    		 42,174 2022-05-26 0

    MILLER JOAN W.

    • Director
    		 57,700 2022-05-26 0

    BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC

    BAIN CAPITAL LIFE SCIENCES PARTNERS, LP

    BAIN CAPITAL LIFE SCIENCES FUND, L.P.

    BCIP LIFE SCIENCES ASSOCIATES, LP

    SCHWARTZ JEFFREY LAWRENCE

    KOPPEL ADAM

    • Director
    • 10% Owner
    		 8,891,758 2020-10-26 0

    ADAMS STREET PARTNERS LLC

    • 10% Owner
    		 5,305,872 2020-09-30 0

    GANTZ WILBUR H

    • Director
    		 0 2020-03-31 0

    TOPPER JAMES N

    • Director
    		 3,195,055 2020-03-31 0

    BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC

    BAIN CAPITAL LIFE SCIENCES PARTNERS, LP

    BAIN CAPITAL LIFE SCIENCES FUND, L.P.

    BCIP LIFE SCIENCES ASSOCIATES, LP

    SCHWARTZ JEFFREY LAWRENCE

    • 10% Owner
    		 5,558,425 2020-01-14 0

    MOSKAL JOSEPH R. CHIEF SCIENTIFIC OFFICER

    • Officer
    		 0 2019-05-16 0

    RATCLIFFE LIAM

    • Director
    		 0 2019-03-29 0

    MADSEN TORSTEN M. CHIEF MEDICAL OFFICER

    • Officer
    		 232,600 2019-01-28 0

    HOUCK DAVID CHIEF DEVELOPMENT OFFICER

    • Officer
    		 0 2019-01-04 0

    FRAZIER LIFE SCIENCES VIII, L.P.

    FHM LIFE SCIENCES VIII, L.P.

    FHM LIFE SCIENCES VIII, L.L.C.

    HERON PATRICK J

    • 10% Owner
    		 No longer subject to file 2018-06-25 0

    LONGITUDE CAPITAL PARTNERS II, LLC

    TAMMENOMS BAKKER JULIET

    LONGITUDE VENTURE PARTNERS II, L.P.

    • 10% Owner
    		 No longer subject to file 2018-06-25 0

    NEW LEAF VENTURE MANAGEMENT III, L.L.C.

    NEW LEAF VENTURE ASSOCIATES III, L.P.

    NEW LEAF VENTURES III, L.P.

    NEW LEAF BIOPHARMA OPPORTUNITIES I, L.P.

    NEW LEAF BPO ASSOCIATES I, L.P.

    • 10% Owner
    		 No longer subject to file 2018-06-25 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    APTINYX INC APTX 2023-09-29 22:15:03 UTC -7.0472 12.3672 6000000
    APTINYX INC APTX 2023-09-29 21:45:04 UTC -7.0472 12.3672 6000000
    APTINYX INC APTX 2023-09-29 21:15:03 UTC -7.0472 12.3672 6000000
    APTINYX INC APTX 2023-09-29 20:45:05 UTC -7.0472 12.3672 6000000
    APTINYX INC APTX 2023-09-29 20:15:04 UTC -7.0472 12.3672 6000000
    APTINYX INC APTX 2023-09-29 19:45:04 UTC -7.0472 12.3672 6000000
    APTINYX INC APTX 2023-09-29 19:15:03 UTC 0.0 0.0 6000000
    APTINYX INC APTX 2023-09-29 18:45:03 UTC 0.0 0.0 6000000
    APTINYX INC APTX 2023-09-29 18:15:03 UTC 0.0 0.0 6000000
    APTINYX INC APTX 2023-09-29 17:45:03 UTC -7.0472 12.3672 6000000
    APTINYX INC APTX 2023-09-29 17:15:04 UTC -7.0472 12.3672 6000000
    APTINYX INC APTX 2023-09-29 16:45:04 UTC -7.0472 12.3672 6000000
    APTINYX INC APTX 2023-09-29 16:15:03 UTC -7.0472 12.3672 6000000
    APTINYX INC APTX 2023-09-29 15:45:04 UTC -7.0472 12.3672 6000000
    APTINYX INC APTX 2023-09-29 15:15:04 UTC -7.0472 12.3672 6000000
    APTINYX INC APTX 2023-09-29 14:45:04 UTC -7.0472 12.3672 6000000
    APTINYX INC APTX 2023-09-29 14:15:04 UTC -7.0472 12.3672 6000000
    APTINYX INC APTX 2023-09-29 13:45:03 UTC -6.7571 12.0771 6000000
    APTINYX INC APTX 2023-09-29 13:15:04 UTC -6.7571 12.0771 6000000
    APTINYX INC APTX 2023-09-29 12:45:05 UTC -6.7571 12.0771 6000000

    Current Active Short Positions

    Get more info on our International short position coverage here

    Holder Issuer Net Short Position Position Date Origin

    Short Position History (International Only)

    Holder Net Short Position Position Date Origin
    Squarepoint Ops LLC Aptinyx Inc 0.92% 2019-08-15 UK
    Squarepoint Ops LLC Aptinyx Inc 0.89% 2019-08-29 UK
    Squarepoint Ops LLC Aptinyx Inc 0.75% 2019-10-04 UK
    Squarepoint Ops LLC Aptinyx Inc 0.69% 2019-10-16 UK
    Squarepoint Ops LLC Aptinyx Inc 0.56% 2019-11-08 UK

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    WhaleWisdom Logo

    Elevate your investments